Annual breast cancer cases are estimated to rise by a third worldwide from 2023 to 2050, according to new research published in The Lancet Oncology.
Deaths from breast cancer are also projected to increase by 44% during that time.
“Breast cancer continues to take a profound toll on women’s lives and communities,” lead study author Kayleigh Bhangdia, MS, a research scientist at the Institute for Health Metrics and Evaluation (IHME), University of Washington, Seattle, said in a press release. “While those in high-income countries typically benefit from screening and more timely diagnosis and

Among adults with relapsing MS who received ublituximab, the annualized relapse rate continued to drop with up to 5 years of treatment, according to an interim open-label extension study analysis published in JAMA Neurology.
“This study shows two very important features that clinicians need to understand about ublituximab use,” Bruce A. C. Cree, MD, PhD, MAS, professor of clinical neurology and George A. Zimmermann Endowed Professor in Multiple Sclerosis at the University of California, San Francisco, told Healio. “The first is that ublituximab treatment has robust impacts on prevention of MS

Nuance Audio Glasses boost the ability to understand speech in noisy environments, and participants prefer wearing them rather than not wearing them, according to a study published in Journal of Otolaryngology-ENT Research.
“Although conventional prescription hearing aids can be effective in managing hearing and listening difficulties, barriers such as cost, stigma and limited access to hearing health care professionals hinder adoption,” Tami Harel-Arbeli, PhD, chief of audiology at Nuance Audio, EssilorLuxottica, and colleagues wrote. “As a novel over-the-counter solution, Nuance Audio

The quest to contain gonorrhea has been a decades-long struggle, but there is hope on the horizon in the form of new medications, clinicians said.
In December, the FDA approved the first two new antibiotics for gonorrhea in nearly 40 years: Blujepa (gepotidacin, GSK) and Nuzolvence (zoliflodacin, Innoviva Specialty Therapeutics). With these, clinicians look to take the upper hand on a pathogen — Neisseria gonorrhoeae — that has ducked and dodged nearly every antibiotic used for treatment.
“There’s great hope and enthusiasm in the STI community for these new treatment options,” Jodie A. Dionne,

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.
An evaluation of 1-year survival data showed significant mortality increases for multiple malignancies, including lung, colorectal, pancreatic and prostate cancer.
“Our goal is to save lives, to reduce unnecessary loss of life,” Todd Burus, PhD, assistant professor of internal medicine at University of Kentucky College of Medicine, told Healio. “During the COVID-19 pandemic, [health care] really focused on reducing unnecessary

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.
It seems too simple to be true that we could shine a light in someone’s eyes for a few minutes nine times every 4 months and that it would help either regenerate or slow the aging process in the retina. The premise is that shining a combination of three wavelengths of light (590 nm, 660 nm and 850 nm) into the eye helps activate the mitochondria in retinal cells.
The study to gain FDA authorization was relatively small, 148 eyes over 2

NEW ORLEANS — Results showed saline had similar results in preventing periprosthetic joint infection within 1 year of total hip arthroplasty compared with dilute povidone-iodine lavage, vancomycin powder or a combination strategy.
“Using vancomycin powder or Betadine irrigation solution is no different or more effective than using normal saline for irrigation in your total hip and knee arthroplasty cases,” Joshua C. Rozell, MD, of NYU Langone Orthopedics, told Healio about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.
Rozell, along with

NEW ORLEANS — Results showed that use of GLP-1 receptor agonists did not increase short-term medical or surgical complications among patients with type 2 diabetes undergoing fixation for femoral neck fracture.
“Patients on GLP-1 agonists have lower revision of their previous hip surgery to a total hip arthroplasty compared with patients not on a GLP-1 agonist,” McKenna W. Box, MD, second year resident at the Medical City Denton Orthopedic Surgery Residency program in Denton, Texas, told Healio. “Since our population was small, it is our hope that, with future studies

An individualized, patient-centered approach is crucial for health care professionals who are prescribing obesity medications, according to the latest chapter of the Standards of Care in Overweight and Obesity.
The Obesity Association, a subdivision of the American Diabetes Association, released a chapter on the pharmacologic treatment of obesity in Diabetes, Obesity, and Cardiometabolic CARE in January. The chapter outlines all of the FDA-approved obesity medications, details which drugs work best for patients with a wide range of cardiometabolic conditions and provides guidance on how to

The FDA announced approval of a generic of Flovent hydrofluoroalkane inhalation aerosol for the maintenance treatment of asthma in patients aged 4 years and older as prophylactic therapy, according to a press release.
Flovent hydrofluoroalkane (HFA) contains the corticosteroid fluticasone propionate, and the FDA highlighted that this marks the first generic fluticasone propionate inhalation aerosol (44 µg per actuation) that has received this indication.
As Healio previously reported, GSK stopped manufacturing its Flovent HFA and Flovent Diskus fluticasone propionate inhalers for asthma in